Inhibition Of Dynamin Related Protein 1 To Promote Cell Death

Abstract

The present invention relates to compositions and methods for reducing cell proliferation and/or promoting cell death by inhibiting Drp1. It is based, at least in part, on the discoveries that (i) Drp1 disruption-induced mitochondrial hyperfusion is functionally linked to the cell cycle regulation apparatus, so that Drp1 inhibition results in a disruption of the cell cycle and DNA aberrancies; (ii) inhibition of both Drp1 and ATR are synthetic lethal causing increased DNA damage and apoptotic cell death; and (iii) even in resistant cell lines, Drp1 inhibitor (e.g., mdivi-1) together with a second antiproliferative agent (e.g., cisplatin or carboplatin) act synergistically to promote apoptosis. Accordingly, the present invention provides for novel anticancer strategies.


Claims
Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Nov 15, 2016
  • Application: May 8, 2014
    US US 201414273218 A
  • Priority: May 8, 2014
    US US 201414273218 A
  • Priority: Apr 18, 2012
    US US 201213450345 A
  • Priority: Apr 19, 2011
    US US 201161476759 P

Download Citation


Sign in to the Lens

Feedback